Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Switching from compounded semaglutide to tirzepatide? A doctor explains what to know first

Some people haven't been able to get Ozempic or Zepbound approved by their insurance, and many people don't have insurance at all. Left without options for the big-name brands, a…

DO
By Daniel Okafor · Regulatory Correspondent
Oct 16 19:30 ETSource: Yahoo Creators

From the source

Switching from compounded semaglutide to tirzepatide? A doctor explains what to know first

Some people haven't been able to get Ozempic or Zepbound approved by their insurance, and many people don't have insurance at all. Left without options for the big-name brands, a lot of people who hoped to use GLP-1 medications for weight loss turned to the cheaper compounded versions that filled the gap. Now patients are trading compounded semaglutide for compounded tirzepatide, the copycat of th

Read at creators.yahoo.com
PeptiPrescribed peptides from $99/moSee all →